|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-4-7
|
|
pubmed:abstractText |
Preoperative chemoradiotherapy (CRT) has been widely used to improve local control of disease and to preserve the anal sphincter in the treatment of rectal cancer. However, the response to CRT differs among individual tumors. Our purpose of this study was to identify a set of discriminating genes that can be used for characterization and prediction of response to CRT in rectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/ITGB1BP1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Intracellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/MMP7 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 7,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination),
http://linkedlifedata.com/resource/pubmed/chemical/Tegafur
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1790-6295
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
87-92
|
|
pubmed:meshHeading |
pubmed-meshheading:21471518-Aged,
pubmed-meshheading:21471518-Aged, 80 and over,
pubmed-meshheading:21471518-Antimetabolites, Antineoplastic,
pubmed-meshheading:21471518-Cluster Analysis,
pubmed-meshheading:21471518-Combined Modality Therapy,
pubmed-meshheading:21471518-Drug Combinations,
pubmed-meshheading:21471518-Female,
pubmed-meshheading:21471518-Gene Expression Profiling,
pubmed-meshheading:21471518-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:21471518-Humans,
pubmed-meshheading:21471518-Immunohistochemistry,
pubmed-meshheading:21471518-Intracellular Signaling Peptides and Proteins,
pubmed-meshheading:21471518-Male,
pubmed-meshheading:21471518-Matrix Metalloproteinase 7,
pubmed-meshheading:21471518-Membrane Proteins,
pubmed-meshheading:21471518-Middle Aged,
pubmed-meshheading:21471518-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:21471518-Oxonic Acid,
pubmed-meshheading:21471518-Predictive Value of Tests,
pubmed-meshheading:21471518-Preoperative Care,
pubmed-meshheading:21471518-Prognosis,
pubmed-meshheading:21471518-Radiotherapy,
pubmed-meshheading:21471518-Rectal Neoplasms,
pubmed-meshheading:21471518-Tegafur
|
|
pubmed:articleTitle |
Gene expression profile can predict pathological response to preoperative chemoradiotherapy in rectal cancer.
|
|
pubmed:affiliation |
Department of Surgery, Institute of Health Biosciences, The University of Tokushima, Kuramoto, Tokushima, Japan. mnishioka@clin.med.tokushima-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
